Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Other Operating Expenses: 2020-2024

Historic Other Operating Expenses for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $19.8 million.

  • Journey Medical's Other Operating Expenses rose 29.03% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year decrease of 19.76%. This contributed to the annual value of $19.8 million for FY2024, which is 33.73% down from last year.
  • Latest data reveals that Journey Medical reported Other Operating Expenses of $19.8 million as of FY2024, which was down 33.73% from $29.8 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Other Operating Expenses peaked at $55.4 million during FY2021, and registered a low of $14.6 million during FY2020.
  • Over the past 3 years, Journey Medical's median Other Operating Expenses value was $29.8 million (recorded in 2023), while the average stood at $26.8 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 279.90% in 2021, then tumbled by 44.49% in 2022.
  • Yearly analysis of 5 years shows Journey Medical's Other Operating Expenses stood at $14.6 million in 2020, then surged by 279.90% to $55.4 million in 2021, then plummeted by 44.49% to $30.8 million in 2022, then fell by 3.16% to $29.8 million in 2023, then plummeted by 33.73% to $19.8 million in 2024.